<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/0838B2E1-D5E2-4ACD-AA27-D2B1BFDC124F"><gtr:id>0838B2E1-D5E2-4ACD-AA27-D2B1BFDC124F</gtr:id><gtr:name>University of Bradford</gtr:name><gtr:department>Sch of Life Sciences</gtr:department><gtr:address><gtr:line1>Richmond Road</gtr:line1><gtr:line4>Bradford</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>BD7 1DP</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0838B2E1-D5E2-4ACD-AA27-D2B1BFDC124F"><gtr:id>0838B2E1-D5E2-4ACD-AA27-D2B1BFDC124F</gtr:id><gtr:name>University of Bradford</gtr:name><gtr:address><gtr:line1>Richmond Road</gtr:line1><gtr:line4>Bradford</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>BD7 1DP</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0375F088-818A-437C-9B0F-0610197366AB"><gtr:id>0375F088-818A-437C-9B0F-0610197366AB</gtr:id><gtr:firstName>Sheila</gtr:firstName><gtr:surname>MacNeil</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/18399BAB-0F5F-40AC-A58F-4E46BED16C50"><gtr:id>18399BAB-0F5F-40AC-A58F-4E46BED16C50</gtr:id><gtr:firstName>Simon J.</gtr:firstName><gtr:surname>Foster</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EBF20BC0-CB18-4CDB-BC76-B24CA8663C07"><gtr:id>EBF20BC0-CB18-4CDB-BC76-B24CA8663C07</gtr:id><gtr:firstName>Joanna</gtr:firstName><gtr:surname>Shepherd</gtr:surname><gtr:orcidId>0000-0001-7661-0698</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/600EFA0A-33F2-430A-B92E-BFE80D4223E2"><gtr:id>600EFA0A-33F2-430A-B92E-BFE80D4223E2</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Douglas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EDC40B5C-DF26-4501-8C22-F5EAF6B53F58"><gtr:id>EDC40B5C-DF26-4501-8C22-F5EAF6B53F58</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Rimmer</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FN501888%2F2"><gtr:id>2EDD60A7-B601-48D2-AB80-FA578F640A75</gtr:id><gtr:title>UK-India Centre for Advanced Technology for Minimising the indiscriminate use of</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/N501888/2</gtr:grantReference><gtr:abstractText>Resistance to antibiotics is becoming one of the most important challenges of our age. A number of challenges exist if we are to avoid decent into a post-antibiotic age, including development of: new antibiotics; new diagnostics and improved delivery systems. The UK-India Centre for Advanced Technology for Minimising the indiscriminate use of Antibiotics (UKICAT-MA) will establish materials for both detection, at the point-of-care, of ocular infections and the targeted delivery of antibiotics to infected sites in the eye. UKICAT-MA will also promote the use of these technologies in other infective diseases. The Centre involves a multidisciplinary team from the University of Sheffield (Polymer Chemistry, Clinical and Mechanistic Microbiology and LV Prasad Ophthalmology). Much of the work is based around the idea that certain materials respond to bacteria by changing state on binding to bacteria. These conformational changes are then either monitored to provide a signal of the presence of the bacteria or they provide a basis for targeting antibiotics to bacteria whilst reducing effects on surrounding tissues. UKICAT-MA will develop these smart materials to produce contact lenses that give colourimetric indications of bacterial infections and systems for local delivery of therapeutics to infected ocular tissues. The Centre involves basic science activities, which are aimed at understanding the binding interactions that are key aspects of these materials, materials development and development of manufacturing strategies through to clinical trials. Close collaborative working between the UK and India will facilitate this ambitious programme and each partner brings important expertise to progress these technologies efficiently and quickly to the clinic. UKICAT-MA will also look to collaborate with new partners: industrial, clinical and scientific with expertise of infections other than in eyes. To facilitate these further researches we will run a series of workshops in both India and the UK.</gtr:abstractText><gtr:technicalSummary>Resistance to antibiotics is becoming one of the most important challenges of our age. A number of challenges exist if we are to avoid decent into a post-antibiotic age, including development of: new antibiotics; new diagnostics and improved delivery systems. The UK-India Centre for Advanced Technology for Minimising the indiscriminate use of Antibiotics (UKICAT-MA) will establish materials for both detection, at the point-of-care, of ocular infections and the targeted delivery of antibiotics to infected sites in the eye. UKICAT-MA will also promote the use of these technologies in other infective diseases. The Centre involves a multidisciplinary team from the University of Sheffield (Polymer Chemistry, Clinical and Mechanistic Microbiology and LV Prasad Ophthalmology). Much of the work is based around the idea that certain materials respond to bacteria by changing state on binding to bacteria. These conformational changes are then either monitored to provide a signal of the presence of the bacteria or they provide a basis for targeting antibiotics to bacteria whilst reducing effects on surrounding tissues. UKICAT-MA will develop these smart materials to produce contact lenses that give colourimetric indications of bacterial infections and systems for local delivery of therapeutics to infected ocular tissues. The Centre involves basic science activities, which are aimed at understanding the binding interactions that are key aspects of these materials, materials development and development of manufacturing strategies through to clinical trials. Close collaborative working between the UK and India will facilitate this ambitious programme and each partner brings important expertise to progress these technologies efficiently and quickly to the clinic. UKICAT-MA will also look to collaborate with new partners: industrial, clinical and scientific with expertise of infections other than in eyes. To facilitate these further researches we will run a series of workshops in both India and the UK.</gtr:technicalSummary><gtr:fund><gtr:end>2018-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>904805</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC/DBT Workshop UK-India Centre for Advanced Technologies-Minimising the indiscriminate use of Antibiotics (UKICAT-MA)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3E99490E-D0B1-4204-AB23-1648905A8E73</gtr:id><gtr:impact>On 14/15th March 2016 we held a MRC/DBT funded workshop on the theme of
 Materials to Combat Antibiotic Resistance. The workshop was part of a continuing
 series of events that are part of the work of UK-India Centre for Advanced
 Technologies-Minimising the indiscriminate use of Antibiotics (UKICAT-MA). The
 following is the collection of presentations and the results of discussions highlighting
 key themes for future work by this group.
 Combating antibiotic resistance is perhaps the biggest issue facing the global
 community in the 21st century and no other area, with the exception perhaps of
 nuclear conflict, has the capacity to significantly reduce living standards and mortality
 rates. Key objectives identified by WHO1 in this area among five key aspects,
 include:
 Objective 4-to optimize the use of antimicrobial agents
 Objective 5-new medicines, diagnostic tools, vaccines and other interventions
 Our aims in this series of workshops are to provide an Indo-UK forum for:
 discussions of our advances in providing technologies to address these objectives;
 facilitate the interface between UK and Indian clinicians, materials and biological
 scientists and to identify key areas for new projects. An important aspect of the work
 in a global context is that by combining the UK and Indian community and clinical
 experiences we cover most of the scenarios that the global population might expect to
 encounter</gtr:impact><gtr:outcomeId>578829f737d340.36317857</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://hdl.handle.net/10454/8622</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd MRC/DBT Workshop UK-India Centre for Advanced Technologies-Minimising the indiscriminate use of Antibiotics (UKICAT-MA)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ACB0CFBC-B013-422A-97E6-FA1A86DB3072</gtr:id><gtr:impact>The purpose of this workshop was to promote interdisciplinary learning and collaborations between
UK and India in the area of bacteria and wounds, particularly when bacteria are increasingly antibiotic
resistant.</gtr:impact><gtr:outcomeId>57d7c743847966.75229386</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://bradscholars.brad.ac.uk/handle/10454/8770</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E356569B-CA73-4452-9050-8DF9A956564C</gtr:id><gtr:title>Binding of Bacteria to Poly(N-isopropylacrylamide) Modified with Vancomycin: Comparison of Behavior of Linear and Highly Branched Polymers.</gtr:title><gtr:parentPublicationTitle>Biomacromolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f718bed449d04edb7defd29b7a1fc16"><gtr:id>8f718bed449d04edb7defd29b7a1fc16</gtr:id><gtr:otherNames>Teratanatorn P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1525-7797</gtr:issn><gtr:outcomeId>5a2fd97f7f59b6.96956941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>029DA7D9-5D2F-4A12-A0D7-47948DCDA754</gtr:id><gtr:title>Core (Polystyrene)-Shell [Poly(glycerol monomethacrylate)] Particles.</gtr:title><gtr:parentPublicationTitle>ACS applied materials &amp; interfaces</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3ccb00e515c65c35fb683d5eacf5dc5"><gtr:id>d3ccb00e515c65c35fb683d5eacf5dc5</gtr:id><gtr:otherNames>Mckenzie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1944-8244</gtr:issn><gtr:outcomeId>58c88d1c5634b5.54460768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AD544FD-165D-48C4-9784-881415BAE02F</gtr:id><gtr:title>A self-healable fluorescence active hydrogel based on ionic block copolymers prepared
 
 ring opening polymerization and xanthate mediated RAFT polymerization</gtr:title><gtr:parentPublicationTitle>Polymer Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027db9c3b84b87202a8838ca43705bf5"><gtr:id>027db9c3b84b87202a8838ca43705bf5</gtr:id><gtr:otherNames>Banerjee S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a995f46150117.16195156</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/N501888/2</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93E3E424-8678-4BDD-9675-2EA16B3EFEA4</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>5.3  Medical devices</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>4CFCFE99-281F-452D-9C77-757ECDBEB0DC</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>6.3  Medical devices</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>